The next Sage? Shkre­li part­ner Lig­and puts to­geth­er an­oth­er sweet start­up pack­age deal for See­los

San Diego-based Lig­and Phar­ma­ceu­ti­cals $LGND has cre­at­ed a start­up li­cens­ing pack­age for a still in­cip­i­ent drug de­vel­op­er, com­plete with a built-in loan and some mod­est up­front terms for a pipeline that in­cludes a Phase III-ready Parkin­son’s drug.

The start­up is called See­los Ther­a­peu­tics, which is reg­is­tered in New York and run by one Raj Mehra.

In the deal, which has an in­ter­est­ing struc­ture, See­los can pay $1.3 mil­lion in eq­ui­ty or cash once it rais­es $7.5 mil­lion in ven­ture back­ing. There’s an­oth­er $3.5 mil­lion due if the com­pa­ny be­comes pub­lic. And if cer­tain un­spec­i­fied con­di­tions are met, Lig­and will throw in a $500,000 loan.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.